Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs
April 8, 2020
LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related immune response to COVID-19 MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced [...]
EDAX Announces Sales Agreement with Angstrom Scientific
April 8, 2020
MAHWAH, NJ, April 8, 2020 – EDAX, Inc., a leader in X-ray microanalysis and electron diffraction instrumentation, has signed a distributor agreement with Angstrom Scientific. The agreement allows Angstrom Scientific to sell all EDAX products in the United States. “We are excited to welcome Angstrom Scientific to the EDAX sales team,” said EDAX U.S. Sales Manager, [...]
H.E.L Group appoints Kevin O’Donovan as Chair
April 7, 2020
Appointment brings significant Board and commercial experience to deliver sustainable company growth Borehamwood, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Kevin O’Donovan as Chair of the H.E.L Board of Directors. Kevin takes over from interim Chair, Jon Andrew, and [...]
Organovo Announces Termination of Merger Agreement with Tarveda Therapeutics
April 7, 2020
SAN DIEGO -- Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) announced today that it has terminated the merger agreement with Tarveda Therapeutics, Inc. (“Tarveda”), originally announced on December 16, 2019, and will continue to operate as an independent company. The Company had submitted the merger proposal and other related proposals to be voted upon at a Special Meeting of Stockholders, as described [...]
Tarveda Therapeutics Provides Update on Proposed Merger with Organovo
April 7, 2020
— Unanticipated late opposition by major Organovo stockholder results in termination of proposed merger agreement — — Tarveda continues advancement of current Pentarin® miniature drug conjugate clinical programs towards key clinical milestones — Watertown, MA – Tarveda Therapeutics, Inc. (“Tarveda”), a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it [...]
SP Scienceware Launches New ProCulture® Product Line
April 7, 2020
WAYNE, N.J. -- ProCulture®, the new workflow-minded product line for cell culture from Bel-Art and Wilmad-LabGlass brands, covers multiple steps of the cell culture process from isolation to harvesting. Products include an array of Shaker Flasks, Spinner Flasks with a unique impeller that increases aeration and eliminates dead spots, and an Orbital Shaker Platform that converts an [...]
Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
April 7, 2020
Merck today announced that the United States Patent and Trademark Office has granted the company's patent for CRISPR-chrom technology. CRISPR-chrom technology improves access to genome for more efficient editing Only U.S. patent holder in the CRISPR chromatin space Company driving innovation in CRISPR gene-editing technologies Darmstadt, Germany -- Merck, a leading science and technology [...]
April 7, 2020
New content and Interpret NGS analysis software detection capabilities include BCR-ABL and KMT2A-PTD detection Oxford, UK – Oxford Gene Technology (OGT), A Sysmex Group Company, announces the addition of accurate detection capabilities for translocations and difficult-to-sequence partial tandem duplications (PTDs) in its popular myPanel™ customisable SureSeq™ NGS panels. This latest update is, for example, beneficial to researchers investigating [...]
April 6, 2020
Pioneering DNA synthesis company - inventor of the Gibson Assembly method and the BioXp system - furthers its mission to empower researchers in moving from reading DNA to writing and printing DNA SAN DIEGO, California SGI-DNA, Inc. creators of the world's first fully automated system for high-throughput writing of DNA, the BioXp 3200 system, today [...]
April 6, 2020
Polyplus-transfection® SA, the leading biotechnology company that supports the gene and cell therapy market by supplying innovative transfection solutions, today announces it will make available to the market a novel transfection reagent FectoVIR®-AAV in May 2020. The reagent has been specifically developed to improve AAV (adeno-associated virus) production in suspension cell culture system for large-scale [...]

